Podimetrics
Podimetrics is a virtual care company that provides FDA-cleared SmartMat thermometry devices and clinical monitoring services to health plans, providers, employers, and the VA to prevent diabetic foot ulcers and amputations in high-risk patients with complex diabetes.
- Company typePrivate
- Founded2011
- HeadquartersSomerville, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Podimetrics does
Podimetrics is a virtual care management company focused on preventing diabetic foot complications in high-risk patients with complex diabetes. Founded in 2011 and headquartered in Somerville, Massachusetts, the company combines FDA-cleared proprietary hardware (the SmartMat thermometry device and its next-generation successor SmartMat+) with a clinical monitoring service in which its care team continuously reviews patient data and coordinates with providers. The SmartMat measures plantar foot temperature asymmetry to detect inflammation up to approximately five weeks before a diabetic foot ulcer manifests, while SmartMat+ adds weight and balance measurement (using Center of Pressure velocity analysis) to monitor additional complex diabetes complications including heart failure signs and fall risk. Devices transmit data via cellular networks, requiring no Wi-Fi or Bluetooth from patients, and store up to 30 scans when transmission is unavailable.
The company generates revenue primarily through enterprise subscription contracts, with health plans (Medicare Advantage, Medicaid, commercial), integrated health systems, employers, and the federal VA sponsoring the program for their high-risk members or employees. The program operates under a one-year prescription, with implementation for payors taking approximately 90 days. Podimetrics has demonstrated measurable clinical outcomes, including reported 50-70% reductions in amputations, 91% reduction in moderate-to-severe diabetic foot ulcers, and up to $14K in annual savings per member for payors. The company has raised over $97M cumulatively, including a $45 million Series C led by D1 Capital Partners in March 2022 and $25 million in debt financing from CIBC in November 2022. Certifications include HITRUST, SOC 2 Type 2, ISO 13485, and HIPAA compliance, and the company holds multiple patents covering its asymmetry detection technology.
Podimetrics firmographics
Firmographics- Name
- Podimetrics
- Legal name
- Podimetrics, Inc.
- Website
- https://podimetrics.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Podimetrics is a virtual care company that provides FDA-cleared SmartMat thermometry devices and clinical monitoring services to health plans, providers, employers, and the VA to prevent diabetic foot ulcers and amputations in high-risk patients with complex diabetes.
- Ownership category
- akta.pro rank
Podimetrics industry classification
Industry- Product category
- Diabetic Foot Care / Remote Patient Monitoring
- NAICS
- Home Health Care Services (62161)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Chronic Disease Management IoT (Diabetes, CHF, COPD, Hypertension) (HLACAPAD)
- akta.pro secondary industries
- Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Chronic Disease Remote Monitoring (COPD/CHF/HTN, Weight & Symptom Tracking) (HLAHACAI), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)
Keywords
Where Podimetrics is headquartered
LocationHeadquarters
- HQ city
- Somerville
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Podimetrics business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Virtual Care Program Subscription: Podimetrics provides a virtual care program combining remote monitoring technology (SmartMat/SmartMat+) with personalized clinical support. Most users receive the program through enterprise customer sponsorship (health plans, employers, health systems), where costs are covered by the sponsoring organization for eligible members/employees. The program is covered under a one-year prescription.
- SmartMat Hardware Device: The SmartMat device is provided to patients, typically as part of the program covered by enterprise sponsors (payors, employers, health systems). In some cases, patients can self-pay directly for the device and services. The device measures foot temperature and supports remote monitoring.
- Value-Based Savings / ROI-Driven Contracts: Podimetrics generates revenue by demonstrating cost savings to payors (health plans), with documented outcomes including up to $14K savings per member per year and 30-50% decrease in hospitalizations. The value-based model aligns Podimetrics' revenue with measurable healthcare cost reduction outcomes.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise Sponsorship (Health Plans, Employers, Health Systems) |
| Subscription | Annual | Self-Pay / Out-of-Pocket |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels8 records
Podimetrics product offering
Product offeringCore offering
Podimetrics provides a virtual care program for complex diabetes management, combining FDA-cleared remote temperature-monitoring devices (SmartMat and SmartMat+) with a clinical care team that continuously monitors patient data and intervenes when early signs of diabetic foot complications are detected. The solution targets high-risk individuals with diabetes to prevent diabetic foot ulcers and amputations, and is delivered through enterprise partnerships with health plans, providers, employers, and government health systems.
Product overview
Podimetrics provides a virtual care solution for complex diabetes management, combining remote monitoring devices with personalized clinical support. The core product portfolio includes SmartMat™ (original device measuring foot temperature via thermometry), SmartMat+ (next-generation device with expanded sensors for temperature, weight, and balance), and the Podimetrics Program platform (integrating device data with clinical oversight, patient engagement, and provider alerts). The Patient Portal provides users access to their health data and care team communication. The solution focuses on preventing diabetic foot ulcers and related complications through early detection using temperature asymmetry monitoring.
Differentiator
Problem solved
Functional benefit
Brands
- SmartMat: FDA-cleared device that measures foot temperature for early detection of diabetic foot ulcers
- SmartMat+
Products and services
- SmartMat™ FDA-cleared, cellular-connected remote monitoring device that measures plantar foot temperature through a soft, compliant sensor system. Patients step on the mat for 20 seconds daily; the device captures a full thermogram of both feet and transmits data to the Podimetrics clinical care team for early detection of inflammation that may precede diabetic foot ulcers, up to five weeks before a wound opens.
- SmartMat+ Next-generation remote monitoring device that measures foot temperature, weight, and balance (using Center of Pressure velocity compared to baseline) and includes a 4.3-inch detachable LCD controller display. Designed for individuals with complex diabetes, it supports early detection of foot ulcers, fall risk, and signs of heart failure, and pairs with the Podimetrics clinical care team for proactive intervention.
- Podimetrics Program Comprehensive virtual care solution pairing the SmartMat/SmartMat+ devices with continuous clinical monitoring by the Podimetrics care team, personalized patient outreach, provider alerts, and proactive intervention workflows. Sold primarily as an enterprise program to health plans, providers, employers, and health systems, with a self-pay option for individual patients, to prevent diabetic foot ulcers and amputations in high-risk diabetic populations.
Quantifiable outcome
- 50-70% reduction in amputations
- +9 more outcomes
Companies that use Podimetrics
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles4 records
Podimetrics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature5 records
Podimetrics partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- American Diabetes Association (ADA) Amputation Prevention AlliancecorePodimetrics is a founding member of the American Diabetes Association Amputation Prevention Alliance, focused on saving limbs and lives. The alliance focuses on advancing policy changes, driving clinician awareness of amputation prevention opportunities, and empowering patients to advocate for their best care.
Scale indicators7 records
Recent moves5 records
Expansion highlights5 records
Podimetrics competitors and assessment
Company assessmentDirect peers
- Siren: Siren makes smart socks with embedded temperature sensors that detect early signs of diabetic foot ulcers. It is the most direct competitive comparison to Podimetrics — both serve high-risk diabetic patients with remote thermometry-based devices to prevent DFUs and amputations, sold primarily to payors and providers.
- Orpyx Medical Technologies: Orpyx produces sensor-based insoles (Orpyx SI) for diabetic foot ulcer prevention and remote patient monitoring. It competes directly with Podimetrics in the thermometry/sensor-based DFU prevention category targeting high-risk diabetic patients.
Broad incumbents
- Dexcom: Dexcom is the leader in continuous glucose monitoring (CGM) for diabetes management. While its product is glucose-focused, Dexcom has the payor relationships, diabetes brand, and capital to expand into adjacent RPM categories like DFU prevention, making it a credible long-term competitive threat.
- Abbott Diabetes Care: Abbott's FreeStyle Libre is the dominant CGM franchise globally. As a major medtech incumbent in diabetes, Abbott has the scale and payor access to bundle adjacent monitoring capabilities (e.g., foot health) into its diabetes platform, positioning it as a broad incumbent threat to Podimetrics.
- Insulet: Insulet (Omnipod) is a leading tubeless insulin pump company serving complex diabetes patients — a population that overlaps with Podimetrics' high-risk DFU target. Insulet's established payor relationships and diabetes-focused commercial team make it a relevant incumbent comparable.
- Omada Health: Omada Health is a digital chronic care management company with a diabetes prevention and management program sold to employers and payors. It targets similar enterprise buyers and chronic-disease populations, positioning it as a broad-incumbent virtual care peer to Podimetrics.
- Virta Health: Virta Health provides a virtual diabetes reversal and management platform sold to health plans and employers. While its core modality is nutrition and medication management, it competes for the same payor budget and high-risk diabetes population as Podimetrics.
- mySugr (Roche): mySugr, owned by Roche, is a consumer-facing diabetes management app with strong integration into Roche's Accu-Chek ecosystem. It represents the incumbent pharma/diabetes-supply approach to virtual diabetes care, with partial overlap with Podimetrics' patient engagement and monitoring thesis.
Emerging players
- Glooko: Glooko is a diabetes data management platform that aggregates readings from CGMs, insulin pumps, and connected devices for clinicians and patients. While not a DFU-specific solution, it operates in the same connected-diabetes ecosystem and serves overlapping diabetes care teams.
Others
- Hinge Health: Hinge Health is a virtual musculoskeletal care platform sold to employers and payors. While the clinical focus differs (MSK vs. DFU), Hinge is a useful comp on GTM, payor contracting model, and chronic-condition virtual care unit economics — adjacent rather than directly competitive.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Podimetrics social profiles
Digital presencePodimetrics compliance and trust
Trust signalCompliance4 records
Podimetrics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Podimetrics leadership team
Management profileNumber of profiles
Profiles3 records
Podimetrics funding detail
Funding detailFunding overview
Funding rounds7 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Podimetrics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Podimetrics
What does Podimetrics do?
Podimetrics provides a virtual care program for complex diabetes management, combining FDA-cleared remote temperature-monitoring devices (SmartMat and SmartMat+) with a clinical care team that continuously monitors patient data and intervenes when early signs of diabetic foot complications are detected. The solution targets high-risk individuals with diabetes to prevent diabetic foot ulcers and amputations, and is delivered through enterprise partnerships with health plans, providers, employers, and government health systems.
Is Podimetrics a public or private company?
Podimetrics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Podimetrics founded?
Podimetrics was founded in 2011. It employs 101 to 250 people.
Where is Podimetrics based?
Podimetrics is headquartered in Somerville, United States, in the North America region.
How does Podimetrics make money?
Three revenue lines are on record. Virtual Care Program Subscription is the primary driver. The others are smartMat Hardware Device and value-Based Savings / ROI-Driven Contracts.
Who are Podimetrics's main competitors?
Direct peers on record are Siren and Orpyx Medical Technologies. Broad incumbents are Dexcom, Abbott Diabetes Care, Insulet, Omada Health, Virta Health and mySugr (Roche). Glooko is listed as an emerging player. Hinge Health is listed as an others.
Does Podimetrics have an API?
No public API is recorded for Podimetrics.
What industry is Podimetrics in?
Podimetrics's product category is Diabetic Foot Care / Remote Patient Monitoring. Its primary akta.pro industry code is HLACAPAD, Chronic Disease Management IoT (Diabetes, CHF, COPD, Hypertension), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 62161 and its SIC code is 3841.